-
US Consumer Sentiment Falls to 6-Month Low | Business Matters Full Broadcast (May 10) -
Majority of Americans Believe COVID Shots Cause ‘Unexplained Deaths’
-
Among COVID-19 Vaccines, ‘Novavax Is Probably the Safest’: Dr. Peter McCullough
-
Novavax COVID Vaccine Provides Little Protection Against Infection: Study
-
Novavax Touts Non-mRNA COVID-19 Vaccine, Hopeful to Meet Domestic Production Deadline
-
FDA Authorizes Novavax’s Updated COVID Jab Based on Data From Previous Versions
-
Health Canada Authorizes Updated Pfizer-BioNTech COVID Vaccine
-
FDA Clears New COVID-19 Vaccines in Bid to Counter Waning Effectiveness
-
Vaccine Maker Announces 25 Percent Layoffs as Pandemic Worries Subside
-
Novavax Raises Doubts About Ability to Remain in Business, Shares Fall
-
Novavax COVID-19 Vaccine Associated With Heart Inflammation: Study
-
Novavax to Sell US Government 1.5 Million More Doses of COVID-19 Vaccine
-
Senators Call for Release of COVID-19 Vaccine Agreements
-
Pentagon is ‘Misleading’ Service Members by Promoting Novavax as ‘Ethical’ Vaccine Option, Attorney Alleges
-
CDC Recommends Use of Novavax’s COVID-19 Shot for Adolescents
-
Novavax Seeks FDA Authorization for Emergency Use of COVID-19 Vaccine Booster
-
Novavax Sinks After Halving Sales Forecast on Low Vaccine Demand, Supply Glut
-
Novavax COVID-19 Vaccine Can Cause Heart Inflammation: European Regulator
-
Novavax COVID Vaccines Should Carry Heart Inflammation Warning, EU Says
-
CDC Recommends Novavax COVID-19 Jab for Adults
-
Top Regulator: ‘Severe Allergic Reaction’ a Side Effect of New COVID-19 Vaccine
-
FDA Authorizes ‘Traditional’ Novavax COVID Vaccine, But Critics Question Safety Claims
-
FDA Decision on Novavax COVID-19 Shot May Be Delayed
-
FDA Advisory Panel Recommends Novavax COVID-19 Vaccine for Emergency Use
-
FDA Flags Heart Inflammation Risk Over Novavax COVID-19 Vaccine
-
Novavax’s 22 Percent Post-Earnings Plunge: 5 Factors That Took Toll
-
Novavax COVID-19 Vaccine May Be Issued Emergency Use Authorization in June: FDA
